A Placebo-Controlled, Double-Blind, Randomized, Cross Over Pilot Study Of The Efficacy And Tolerability Of Incobotulinum Toxin A (Xeomin) As A Treatment For Focal Task-Specific Dystonia Of The Musician's Hand
Phase of Trial: Phase II
Latest Information Update: 23 Sep 2016
At a glance
- Drugs Botulinum toxin A (Primary)
- Indications Dystonia
- Focus Therapeutic Use
- 14 Sep 2016 Planned End Date changed from 1 Dec 2017 to 1 Jun 2018.
- 14 Sep 2016 Planned primary completion date changed from 1 Dec 2016 to 1 Jun 2018.
- 30 Jun 2014 New trial record